Meningitec™

BIOLOGICAL6 trials

Sponsors

GlaxoSmithKline

Conditions

Haemophilus Influenzae Type bInfections, MeningococcalNeisseria Meningitidis

Phase 2

Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old

CompletedNCT00196976

GlaxoSmithKlineInfections, Meningococcal

Start: 2005-03-24End: 2006-03-03Updated: 2018-06-08

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

CompletedNCT00427908

GlaxoSmithKlineInfections, Meningococcal

Start: 2007-02-07End: 2007-12-03Updated: 2018-06-04

Phase 3

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

CompletedNCT00322335

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2006-05-31End: 2010-09-30Updated: 2016-10-20

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

CompletedNCT00326118

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2006-06-01End: 2007-11-06Updated: 2018-08-24

Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

CompletedNCT00508261

GlaxoSmithKlineInfections, Meningococcal

Start: 2007-08-01End: 2008-10-27Updated: 2019-01-24

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

CompletedNCT00955682

GlaxoSmithKlineInfections, Meningococcal

Start: 2009-08-25End: 2012-09-10Updated: 2021-02-26

Related Papers

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age

Human Vaccines & Immunotherapeutics2020-06-0215 citations

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents

Human Vaccines & Immunotherapeutics2017-02-0224 citations

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines.

2015-12-0120 citations

Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers.

2015-12-013 citations

Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine

Human Vaccines & Immunotherapeutics2015-11-1729 citations

Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers.

2013-02-015 citations